Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.

Shin K, Lim A, Odegaard JI, Honeycutt JD, Kawano S, Hsieh MH, Beachy PA.

Nat Cell Biol. 2014 May;16(5):469-78. doi: 10.1038/ncb2956. Epub 2014 Apr 20. Erratum in: Nat Cell Biol. 2014 Jun;16(6):620.

2.

Bladder cancer stem cells.

Tran MN, Goodwin Jinesh G, McConkey DJ, Kamat AM.

Curr Stem Cell Res Ther. 2010 Dec;5(4):387-95. Review.

PMID:
20955163
3.

New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.

Gabriel U, Li L, Bolenz C, Steidler A, Kränzlin B, Saile M, Gretz N, Trojan L, Michel MS.

Mol Carcinog. 2012 Nov;51(11):907-15. doi: 10.1002/mc.20860. Epub 2011 Oct 4.

PMID:
21976419
4.

Bladder cancer: finding the origin.

McCarthy N.

Nat Rev Cancer. 2014 Jun;14(6):386-7. doi: 10.1038/nrc3749. Epub 2014 May 15. No abstract available.

PMID:
24827505
5.

The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers.

Hoggarth ZE, Osowski DB, Freeberg BA, Garrett SH, Sens DA, Sens MA, Zhou XD, Zhang KK, Somji S.

PLoS One. 2018 Dec 14;13(12):e0207877. doi: 10.1371/journal.pone.0207877. eCollection 2018.

6.

Sleeping beauty: awakening urothelium from its slumber.

Balsara ZR, Li X.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F732-F743. doi: 10.1152/ajprenal.00337.2016. Epub 2017 Jan 25. Review.

7.

Bladder cancer: root cause of bladder cancer revealed.

Payton S.

Nat Rev Urol. 2014 Jun;11(6):302. doi: 10.1038/nrurol.2014.108. Epub 2014 May 13. No abstract available.

PMID:
24818854
8.

Bladder cancers arise from distinct urothelial sub-populations.

Van Batavia J, Yamany T, Molotkov A, Dan H, Mansukhani M, Batourina E, Schneider K, Oyon D, Dunlop M, Wu XR, Cordon-Cardo C, Mendelsohn C.

Nat Cell Biol. 2014 Oct;16(10):982-91, 1-5. doi: 10.1038/ncb3038. Epub 2014 Sep 14.

PMID:
25218638
9.

Normal and neoplastic urothelial stem cells: getting to the root of the problem.

Ho PL, Kurtova A, Chan KS.

Nat Rev Urol. 2012 Oct;9(10):583-94. doi: 10.1038/nrurol.2012.142. Epub 2012 Aug 14. Review.

10.

Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.

DeGraff DJ, Clark PE, Cates JM, Yamashita H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK, Shariat SF, Steinberg GD, Frierson HF, Wu XR, Theodorescu D, Matusik RJ.

PLoS One. 2012;7(5):e36669. doi: 10.1371/journal.pone.0036669. Epub 2012 May 10.

11.

Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.

Islam SS, Mokhtari RB, Noman AS, Uddin M, Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H, Farhat WA.

Mol Carcinog. 2016 May;55(5):537-51. doi: 10.1002/mc.22300. Epub 2015 Mar 1.

PMID:
25728352
12.

Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.

Ogawa K, St John M, Luiza de Oliveira M, Arnold L, Shirai T, Sun TT, Cohen SM.

Toxicol Pathol. 1999 Nov-Dec;27(6):645-51.

PMID:
10588545
13.

Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.

Garg M.

Cancer Metastasis Rev. 2015 Dec;34(4):691-701. doi: 10.1007/s10555-015-9589-6. Review.

PMID:
26328525
14.
15.

[Update on FGFR3 mutation and multiple regional epigenetic silencing (MRES) phenotype in urothelial carcinogenesis].

Masson-Lecomte A, Vordos D, de la Taille A, Neuzillet Y, Radvanyi F, Allory Y.

Prog Urol. 2013 Feb;23(2):96-8. doi: 10.1016/j.purol.2012.12.003. Epub 2013 Jan 5. French.

PMID:
23352301
16.

Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors.

Shin K, Lim A, Zhao C, Sahoo D, Pan Y, Spiekerkoetter E, Liao JC, Beachy PA.

Cancer Cell. 2014 Oct 13;26(4):521-33. doi: 10.1016/j.ccell.2014.09.001.

17.

Urothelial Cancer Stem Cell Heterogeneity.

Kripnerova M, Parmar HS, Pesta M, Kohoutova M, Kuncova J, Drbal K, Rajtmajerova M, Hatina J.

Adv Exp Med Biol. 2019;1139:127-151. doi: 10.1007/978-3-030-14366-4_8. Review.

PMID:
31134499
18.

High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.

Li W, Liu M, Feng Y, Huang YF, Xu YF, Che JP, Wang GC, Zheng JH.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2430-40. eCollection 2013.

19.

Molecular pathways of urothelial development and bladder tumorigenesis.

Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C.

Urol Oncol. 2010 Jul-Aug;28(4):401-8. doi: 10.1016/j.urolonc.2009.04.019. Review.

PMID:
20610278
20.

Analysis of genetic alterations in normal bladder urothelium.

Leonardo C, Gallucci M, Cianciulli AM.

Urology. 2004 Aug;64(2):405; author reply 405-6. No abstract available.

PMID:
15302516

Supplemental Content

Support Center